The Valley Desk

NCT04103892 · Interventional trial

A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study

Overall registry status Completed

Phase 2

Conditions Adjunctive Treatment of Major Depressive Disorder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov